This trade activity should not be overlooked: Black Diamond Therapeutics Inc (BDTX)

With 0.82 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.26 million shares. The 52-week range on BDTX shows that it touched its highest point at $7.50 and its lowest point at $1.20 during that stretch. It currently has a 1-year price target of $13.00. Beta for the stock currently stands at 2.65.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BDTX was down-trending over the past week, with a drop of -8.82%, but this was up by 13.97% over a month. Three-month performance dropped to -43.01% while six-month performance fell -46.37%. The stock lost -77.73% in the past year, while it has lost -27.57% so far this year. A look at the trailing 12-month EPS for BDTX yields -1.27 with Next year EPS estimates of -0.97. For the next quarter, that number is 0.20. This implies an EPS growth rate of 56.48% for this year and -76.26% for next year. EPS is expected to decline by -0.85% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -5.22%.

Float and Shares Shorts:

At present, 56.64 million BDTX shares are outstanding with a float of 43.15 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BDTX since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.23943 being high and -$1.33938 being low. For BDTX, this leads to a yearly average estimate of -$1.2994. Based on analyst estimates, the high estimate for the next quarter is -$0.15 and the low estimate is -$0.33. The average estimate for the next quarter is thus -$0.25.